World's Best Scientists 2026 revealed!
Bengt I. Eriksson

Bengt I. Eriksson

D-Index & Metrics

Medicine

D-Index
89
Citations
36029
World Ranking
12521
National Ranking
236

Bengt I. Eriksson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bengt I. Eriksson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 244 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bengt I. Eriksson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bengt I. Eriksson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bengt I. Eriksson is affiliated with the University of Gothenburg in Sweden. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a particular focus on several subfields including Infectious Diseases, Virology, Immunology, Microbiology, and Surgery.

The scientist's scholarly output includes a range of papers addressing various topics related to medical science and infectious diseases. Recent publications include:

  • Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses (2023, Nature Communications)
  • Complete mid-portion rupture of the rat achilles tendon leads to remote and time-mismatched changes in uninjured regions (2020, Knee Surgery Sports Traumatology Arthroscopy)
  • Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses (2023, Nature Communications)
  • How Aware and Active is the Swedish Building and Real Estate Sector in Climate-Smart Concrete? (2022, International Journal of Engineering Trends and Technology)
  • Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses (2023, Zenodo (CERN European Organization for Nuclear Research))

These publications reflect involvement in diverse research topics, including vaccine development, tendon injury, and sustainable building materials, although the majority are concentrated on infectious diseases and immunology-related subjects.

Their frequent co-authors include:

  • Karin Loré
  • Fredrika Hellgren
  • Rodrigo Arcoverde Cerveira
  • Sebastian Ols
  • Alberto Cagigi

Key publication venues for Bengt I. Eriksson are:

  • Nature Communications (three publications)
  • Knee Surgery Sports Traumatology Arthroscopy
  • Zenodo (CERN European Organization for Nuclear Research)
  • Lab Animal
  • International Journal of Engineering Trends and Technology

The scientist's research topics cover a number of significant areas, including:

  • Rabies epidemiology and control
  • Viral infections and outbreaks research
  • Microbial infections and disease research
  • Tendon structure and treatment
  • Shoulder injury and treatment
  • Orthopedic surgery and rehabilitation
  • Hepatitis B virus studies

Best Publications

  • Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

    S. Schulman;U. Angerås;D. Bergqvist;B. Eriksson

  • Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

    Bengt I. Eriksson;Lars C. Borris;Richard J. Friedman;Sylvia Haas

  • Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

    Bengt I Eriksson;Ola E Dahl;Nadia Rosencher;Andreas A Kurth

  • Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

    Ajay K. Kakkar;Benjamin Brenner;Ola E. Dahl;Bengt I. Eriksson

  • Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

    B. I. Eriksson;O. E. Dahl;N. Rosencher;A. A. Kurth

  • Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

    Alexander G. G. Turpie;Kenneth A. Bauer;Bengt I. Eriksson;Michael R. Lassen

  • Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery

    Eriksson Bi;Bauer Ka;Lassen Mr;Turpie Ag

  • Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

    K A Bauer;B I Eriksson;M R Lassen;A G Turpie

  • Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

    Alexander G G Turpie;Kenneth A Bauer;Bengt I Eriksson;Michael R Lassen

  • Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

    Bengt I. Eriksson;Daniel J. Quinlan;Jeffrey I. Weitz

  • A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

    Eriksson Bi;Dahl Oe;Büller Hr;Hettiarachchi R

  • Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*): A randomised, double-blind, non-inferiority trial

    Bengt I. Eriksson;Ola E. Dahl;Michael H. Huo;Andreas A. Kurth

  • A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement

    Bengt I. Eriksson;Peer Wille-Jørgensen;Peter Kälebo;Patrick Mouret

  • Acute Achilles Tendon Rupture A Randomized, Controlled Study Comparing Surgical and Nonsurgical Treatments Using Validated Outcome Measures

    Katarina Nilsson-Helander;Karin Grävare Silbernagel;Karin Grävare Silbernagel;Roland Thomeé;Eva Faxén

  • The Achilles Tendon Total Rupture Score (ATRS) Development and Validation

    Katarina Nilsson-Helander;Roland Thomeé;Karin Grävare-Silbernagel;Pia Thomeé

  • Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

    Bengt I. Eriksson;Michael R. Lassen

  • A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement

    Bengt I. Eriksson;Lars C. Borris;Ola E. Dahl;Sylvia Haas

  • Continued Sports Activity, Using a Pain-Monitoring Model, During Rehabilitation in Patients With Achilles Tendinopathy A Randomized Controlled Study

    Karin Grävare Silbernagel;Roland Thomeé;Roland Thomeé;Bengt I. Eriksson;Jon Karlsson

  • Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

    B. I. Eriksson;L. Borris;O. E. Dahl;S. Haas

  • Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.

    Joachim Stangier;Bengt I. Eriksson;Ola E. Dahl;Lennart Ahnfelt

Frequent Co-Authors

Jon Karlsson
Jon Karlsson University of Gothenburg
Alexander G.G. Turpie
Alexander G.G. Turpie McMaster University
Kenneth A. Bauer
Kenneth A. Bauer Beth Israel Deaconess Medical Center
Ajay K. Kakkar
Ajay K. Kakkar University College London
Michael Gent
Michael Gent McMaster University
Giancarlo Agnelli
Giancarlo Agnelli University of Perugia
David Bergqvist
David Bergqvist Uppsala University
Menno V. Huisman
Menno V. Huisman Leiden University Medical Center
Johan Kärrholm
Johan Kärrholm University of Gothenburg
Martin H. Prins
Martin H. Prins Maastricht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and related healthcare degrees online can open numerous career doors beyond traditional medical school. For those looking to advance their nursing credentials, the cheapest dnp programs offer an affordable route to earning a Doctor of Nursing Practice. These programs are ideal for nurses seeking leadership roles without a significant financial burden.

If you are interested in starting your healthcare journey quickly, a lpn fast track program can provide a rapid path to becoming a Licensed Practical Nurse. These programs suit individuals who aim to gain practical experience and enter the workforce as soon as possible.

For those with a passion for mental health, accelerated msn psychiatric np programs are designed for registered nurses eager to specialize and make an impact in psychiatric care. These flexible online programs enable you to upskill quickly and transition into high-demand roles.

If healthcare leadership interests you, consider the cheapest mha programs online, which deliver essential management skills for overseeing healthcare facilities. These degrees are a cost-effective way to move into administrative positions and broader healthcare roles.

Best Scientists Citing Bengt I. Eriksson

Trending Scientists

Recently Published Articles